RxDoctor Payments Data

Heather Mosier

Family · Ashland, OHNPI 1871017038

Payments from drug & device makers

$883in general payments, 2019–2025

Across 54 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$307
  • AstraZeneca$261
  • GSK$63
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
  • Xeris Pharmaceuticals, Inc.$40
  • Johnson & Johnson$35
  • plus $134 from 8 others

What the payments were for

  • Food & beverage$883100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$883 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$4,308
Medicare patients
59
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide28$26,619
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,974
JanuviaSitagliptin Phosphate11$10,635
Breo ElliptaFluticasone/Vilanterol14$10,476
LinzessLinaclotide14$8,553
Spiriva RespimatTiotropium Bromide12$7,704
SymbicortBudesonide/Formoterol Fumarate20$6,528
Incruse ElliptaUmeclidinium Bromide14$4,670
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,805
Albuterol Sulfate HfaAlbuterol Sulfate77$2,435
Omeprazole98$1,179
Buspirone Hcl57$1,023
Atorvastatin Calcium154$922
Bupropion XlBupropion Hcl19$853
FenofibrateFenofibrate Nanocrystallized35$839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$63$30,11947 claims
Lilly USA, LLCTrulicity$20$26,61928 claims
MerckJanuvia$14$10,63511 claims
AbbVieLinzess$307$8,55314 claims
AstraZenecaSymbicort$261$6,52820 claims
Novo NordiskNovolog$14$75211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Ashland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →